Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cg 400549
2. Cg-400549
3. Cg400549
1. 934628-27-0
2. 1-(3-amino-2-methyl-benzyl)-4-(2-thiophen-2-yl-ethoxy)-2-pyridone
3. Cg-400549
4. Nilofabicin
5. Cg400549
6. Cg 400549
7. 1-[(3-amino-2-methylphenyl)methyl]-4-(2-thiophen-2-ylethoxy)pyridin-2-one
8. 4x6t64d64x
9. 1-(3-amino-2-methylbenzyl)-4-[2-(thiophen-2-yl)ethoxy]pyridin-2(1h)-one
10. 2(1h)-pyridinone, 1-((3-amino-2-methylphenyl)methyl)-4-(2-(2-thienyl)ethoxy)-
11. Unii-4x6t64d64x
12. Pt6
13. Nilofabicin [inn]
14. Chembl488937
15. Schembl2177308
16. Gtpl10984
17. Dtxsid00239434
18. Bdbm231620
19. Bcp15467
20. Mfcd09991584
21. Zinc16696900
22. Akos015842354
23. Db12347
24. As-35976
25. Cg-400459
26. Db-012662
27. Hy-111071
28. Cs-0034149
29. Ft-0699236
30. Q-102482
31. Q27260632
32. 1-(3-amino-2-methylbenzyl)-4-(2-thiophen-2-ylmethoxy)-2-pyridone
33. 1-((3-amino-2-methylphenyl)methyl)-4-(2-(2-thienyl)ethoxy)-2(1h)-pyridinone
34. 2(1h)-pyridinone,1-[(3-amino-2-methylphenyl)methyl]-4-[2-(2-thienyl)ethoxy]-
| Molecular Weight | 340.4 g/mol |
|---|---|
| Molecular Formula | C19H20N2O2S |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | 340.12454906 g/mol |
| Monoisotopic Mass | 340.12454906 g/mol |
| Topological Polar Surface Area | 83.8 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 506 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
57
PharmaCompass offers a list of CG400549 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right CG400549 manufacturer or CG400549 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred CG400549 manufacturer or CG400549 supplier.
PharmaCompass also assists you with knowing the CG400549 API Price utilized in the formulation of products. CG400549 API Price is not always fixed or binding as the CG400549 Price is obtained through a variety of data sources. The CG400549 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CG400549 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CG400549, including repackagers and relabelers. The FDA regulates CG400549 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CG400549 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CG400549 supplier is an individual or a company that provides CG400549 active pharmaceutical ingredient (API) or CG400549 finished formulations upon request. The CG400549 suppliers may include CG400549 API manufacturers, exporters, distributors and traders.
CG400549 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CG400549 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CG400549 GMP manufacturer or CG400549 GMP API supplier for your needs.
A CG400549 CoA (Certificate of Analysis) is a formal document that attests to CG400549's compliance with CG400549 specifications and serves as a tool for batch-level quality control.
CG400549 CoA mostly includes findings from lab analyses of a specific batch. For each CG400549 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CG400549 may be tested according to a variety of international standards, such as European Pharmacopoeia (CG400549 EP), CG400549 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CG400549 USP).
